Muntendam Pieter 4
4 · BG Medicine, Inc. · Filed Feb 11, 2011
Insider Transaction Report
Form 4
Muntendam Pieter
DirectorPresident, CEO
Transactions
- Conversion
Common Stock
2011-02-09+9,680→ 9,680 total - Conversion
Series A Preferred Stock
2011-02-09−34,529→ 0 total→ Common Stock (9,680 underlying)
Footnotes (2)
- [F1]The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series A Preferred Stock converted to Common Stock on an approximately 1-for-0.2804 basis.
- [F2]The Series A Preferred Stock automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering and had no expiration date.